NCT00945815 2017-11-06S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaSWOG Cancer Research NetworkPhase 2 Completed35 enrolled 7 charts